CompletedNot Applicable

To Study The Incidence And Outcome Of Paracentesis Induced Circulatory Dysfunction in Decompensated Cirrhotics Undergoing Less Than 5 Litres Of Ascitic Fluid Tap With Or Without Albumin Infusion.

India80 participantsStarted 2015-02-23

Plain-language summary

All consecutive patients admitted in ILBS from MAY 2015 to DECEMBER 2016. Decompensated cirrhosis patients will be randomized into Group 1: MVP (Moderate Volume Paracentesis) of less than 5 litres with iv albumin at a dose 8 gms/l of ascitic fluid Group 1: MVP (Moderate Volume Paracentesis) of less than 5 litres without albumin .

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. All Cirrhotics decompensated with ascites admitted in the hospital.
✓. Grade II/III ascites
✓. Need for paracentesis.

Exclusion criteria

✕. Age \<12 or \> 75 years
✕. Hepatocellular carcinoma
✕. Non cirrhotic ascites such as malignancy or tubercular peritonitis
✕. Serum Cr \>1.5mg%
✕. Refractory septic shock
✕. Grade III/IV hepatic encephalopathy
✕. Abdominal wall cellulitis
✕. Active variceal bleed

What they're measuring

Incidence of PICD (Paracentesis Induced Circulatory Dysfunction).

Timeframe: 1 Year

Trial details

NCT IDNCT02467322

SponsorInstitute of Liver and Biliary Sciences, India

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2016-12-15

View on ClinicalTrials.gov More Decompensated Cirrhosis trials